Skip to main content
Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · IEX Real-Time Price · USD
29.03
-0.28 (-0.96%)
May 17, 2024, 4:00 PM EDT - Market closed

HRMY Revenue

Harmony Biosciences Holdings had revenue of $617.51M in the twelve months ending March 31, 2024, with 30.92% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $154.62M with 29.79% year-over-year growth. In the year 2023, Harmony Biosciences Holdings had annual revenue of $582.02M with 32.93% growth.

Revenue (ttm)
$617.51M
Revenue Growth
+30.92%
P/S Ratio
2.68
Revenue / Employee
$2,510,207
Employees
246
Market Cap
1.65B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023582.02M144.17M32.93%
Dec 31, 2022437.86M132.42M43.35%
Dec 31, 2021305.44M145.70M91.21%
Dec 31, 2020159.74M153.75M2,564.59%
Dec 31, 20196.00M--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tilray Brands 743.25M
U.S. Physical Therapy 611.97M
Taro Pharmaceutical Industries 610.83M
Supernus Pharmaceuticals 597.40M
InMode 466.26M
Schrödinger 188.48M
Revenue Rankings

HRMY News

More News